- In September 2023, Medtronic obtained CE mark approval for its Simplera CGM, a user-friendly, disposable device that integrates with the InPen smart insulin pen, offering real-time, personalized dosing guidance without the need for fingersticks or over-tape application
- In December 2022, Dexcom received U.S. FDA clearance for its next-generation Dexcom G7 continuous glucose monitoring (CGM) system, making it available for individuals aged two years and older with all types of diabetes
- In June 2022, Abbott announced the development of a new biowearable that will continuously monitor both glucose and ketone levels with a single sensor, advancing their portfolio of life-changing healthcare technologies
- In August 2022, Abbott and WW International (WeightWatchers) formed a strategic partnership to help people with diabetes better manage their condition and weight. The collaboration integrates WeightWatchers’ diabetes-specific weight management program with Abbott's FreeStyle Libre products, creating a seamless mobile experience that provides users with insights to improve glucose levels and make healthier dietary choices, ultimately giving them more control over their health
- In November 2022, Senseonics Holdings and Ascensia Diabetes Care announced a collaboration with the Nurse Practitioner Group (NPG) to enhance diabetes care. This partnership combines Senseonics’ long-term implantable CGM systems with Ascensia’s CONTOUR blood glucose monitors to offer comprehensive, multidisciplinary health services, improving diabetes management and patient outcomes
